ARC11: Vasculitis, Arteritis and PMR
Activity Overview
The Advanced Rheumatology Course is a comprehensive 19 module educational series, relevant to advanced practice providers and other professionals who need a deeper dive into rheumatology, with a strong focus on advanced information that will 1) help experienced practice providers function well in rheumatology and 2) foster inter-professional collaboration. This online course is designed to provide advanced comprehensive education to help learners assess and manage patients with rheumatic disease, develop strategies to integrate NP/PAs into rheumatology practice and improve access to care for patients.
*A passing score of 70% or greater on the post-test is required to be eligible to claim CME credits. You can compare your post-test responses to evaluate increased knowledge.
Target Audience
The course was created for nurse practitioners and physician assistants; however, rheumatology fellows-in training, internal medicine residents, medical students, primary care providers and other providers new to rheumatology may also benefit.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Define vasculitis and describe the clinical features and the spectrum of disease entities in which vasculitis is seen.
- Describe the epidemiology, clinical features, differential diagnosis, treatment, and outcome for polymyalgia rheumatica (PMR).
- Describe the epidemiology, clinical features, differential diagnosis, treatment, and outcome of giant cell arteritis (GCA).
- Describe the epidemiology, clinical features, differential diagnosis, treatment, and outcome of granulomatosis with polyangiitis (GPA).
- Describe the epidemiology, clinical features, differential diagnosis, treatment, and outcome of polyarteritis nodosa.
- Describe cutaneous vasculitis and its potential causes, diagnostic evaluation, and therapeutic principles.
CME Information
Accreditation Statement
The American College of Rheumatology (ACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
The ACR designates this enduring online activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Health Professionals
Participants may claim hours to receive a Certificate of Participation for an activity designated for AMA PRA Category 1 Credits™.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board(s).
Faculty & Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity
and Independence in Accredited Continuing Education, ACR has implemented
mechanisms prior to the planning and implementation of this CME activity to
identify and mitigate all relevant financial relationships for all individuals
in a position to control the content of this CME activity.
For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence based, fair balance, and absence of commercial bias.
Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:
- Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Research grants
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
- Receipt of royalties
- Speakers’ bureau
- Other
Author(s):
Anisha Dua, MD - AbbVie/Abbott5, 8; ChemoCentryx5; Novartis5
Josh Waytz, MD – No relevant financial relationships to disclose
Editors and Reviewers:
Paul Monach, MD, PhD – Celgene1; Chemocentryx6; Kiniksa
Anneke Smith – No relevant financial relationships to disclose
Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2
*All of the relevant financial relationships listed for these individuals have been mitigated.
Online Activity Refund Policy
- Requests for cancellations and refunds must be received in writing to education@rheumatology.org within 24 hours of the online activity enrollment date.
- Completed online activities are not eligible for a refund.
- Refunds will be subject to an administration fee per person and per activity: 15% for members; 30% for potential members.
- Canceled online activities are nontransferable.